Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge M W Verberk

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Brain : a Journal of Neurology|December 5, 2020
Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood testCharlotte E Teunissen, Elisabeth H Thijssen, Inge M W Verberk
Annals of Neurology|November 2, 2019
Reply to "Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population"Inge M W Verberk, Charlotte E Teunissen, Wiesje M Van der Flier
Brain : a Journal of Neurology|October 1, 2025
Opposing views or like-minded? International Working Group and Alzheimer's Association criteriaInge M W Verberk, Argonde C van Harten, Wiesje M van der Flier
Journal of Proteome Research|August 22, 2023
Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker DiscoveryKatharina Waury, Renske de Wit, Inge M W Verberk, et al.
JAMA Neurology|May 18, 2026
Amateur Soccer Heading and Acute Elevations in Blood-Based p-Tau217 and S100BMarloes I Hoppen, Marsh Königs, Charlotte E Teunissen, et al.
The Lancet. Healthy Longevity|October 6, 2024
Challenges in the practical implementation of blood biomarkers for Alzheimer's diseaseMichael Schöll, Inge M W Verberk, Marta Del Campo, et al.
Journal of Neurochemistry|September 17, 2024
The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseasesDea Gogishvili, Madison I J Honey, Inge M W Verberk, et al.
Multiple Sclerosis and Related Disorders|February 24, 2021
Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosisInge M W Verberk, Marleen Koel-Simmelink, Harry Twaalfhoven, et al.
Journal of Neurovirology|June 12, 2020
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patientsCharlotte S Hakkers, Anne Marie Hermans, Erik M van Maarseveen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2024
Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family designRebecca Z Rousset, Anouk den Braber, Inge M W Verberk, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Brain : a Journal of Neurology|December 5, 2020
Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood testCharlotte E Teunissen, Elisabeth H Thijssen, Inge M W Verberk
Annals of Neurology|November 2, 2019
Reply to "Usefulness of Plasma Amyloid as Prescreener of the Earliest Alzheimer Pathological Changes Depends on the Study Population"Inge M W Verberk, Charlotte E Teunissen, Wiesje M Van der Flier
Brain : a Journal of Neurology|October 1, 2025
Opposing views or like-minded? International Working Group and Alzheimer's Association criteriaInge M W Verberk, Argonde C van Harten, Wiesje M van der Flier
Journal of Proteome Research|August 22, 2023
Deciphering Protein Secretion from the Brain to Cerebrospinal Fluid for Biomarker DiscoveryKatharina Waury, Renske de Wit, Inge M W Verberk, et al.
JAMA Neurology|May 18, 2026
Amateur Soccer Heading and Acute Elevations in Blood-Based p-Tau217 and S100BMarloes I Hoppen, Marsh Königs, Charlotte E Teunissen, et al.
The Lancet. Healthy Longevity|October 6, 2024
Challenges in the practical implementation of blood biomarkers for Alzheimer's diseaseMichael Schöll, Inge M W Verberk, Marta Del Campo, et al.
Journal of Neurochemistry|September 17, 2024
The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseasesDea Gogishvili, Madison I J Honey, Inge M W Verberk, et al.
Multiple Sclerosis and Related Disorders|February 24, 2021
Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosisInge M W Verberk, Marleen Koel-Simmelink, Harry Twaalfhoven, et al.
Journal of Neurovirology|June 12, 2020
High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patientsCharlotte S Hakkers, Anne Marie Hermans, Erik M van Maarseveen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2024
Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family designRebecca Z Rousset, Anouk den Braber, Inge M W Verberk, et al.
Pageof 8